Notice of Special Interest (NOSI) Targeting Epigenetic Regulators for Treating Addiction and Substance Use Disorders
National Institutes of Health
Description
This grant opportunity invites researchers to conduct basic preclinical studies on enzymes and pathways involved in epigenetic changes caused by addictive drugs. The research aims to develop new drugs, methods, and treatments for substance use disorders and addiction.
The goal of this announcement is to encourage basic preclinical research aimed at identifying and targeting specific enzymes and pathways that play a key role in epigenetic changes induced by addictive drugs with the goal of developing pharmacological tools, methods, and therapeutic intervention…
Source
Grant ID
NOT-DA-24-004
Agency
National Institutes of Health
Subcategory/Subagency
National Institute on Drug Abuse
Key Dates
Opportunity Released
November 3, 2022
Similar opportunities
- Notices of Special Interest (NOSI): High Priority Areas in Genetics, Epigenetics, and Developmental Neuroscience Branch in the Division of Neuroscience and Behavior
National Institutes of Health
- Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
National Institutes of Health
- Collaborative Research on Substance Use Disorders
National Institutes of Health
- Notice of Special Interest (NOSI): Chemoproteomic Approaches for Discovery of Targets and Therapeutics to Treat Substance Use Disorders
National Institutes of Health
- Notice of Special Interest (NOSI): Development and Application of Novel Chemical Approaches to Discover Therapeutic Targets for Substance Use Disorders
National Institutes of Health